Drug Shortage Report for OXALIPLATIN INJECTION
Report ID | 126533 |
Drug Identification Number | 02435071 |
Brand name | OXALIPLATIN INJECTION |
Common or Proper name | OXALIPLATIN INJECTION 5MG/ML |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | OXALIPLATIN |
Strength(s) | 5MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 40ml |
ATC code | L01XA |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-10-14 |
Estimated end date | 2020-11-30 |
Actual end date | 2020-11-25 |
Shortage status | Resolved |
Updated date | 2020-11-26 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2020-11-26 | French | Compare |
v6 | 2020-11-26 | English | Compare |
v5 | 2020-11-06 | French | Compare |
v4 | 2020-11-06 | English | Compare |
v3 | 2020-10-15 | French | Compare |
v2 | 2020-10-15 | English | Compare |
v1 | 2020-10-15 | English | Compare |
Showing 1 to 7 of 7